Company profile: Epinomics
1.1 - Company Overview
Company description
- Provider of deep analytics and proprietary technology to decode the epigenome (the "living genome"), advancing personalized health through scientific research and clinical application development in personalized medicine.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Epinomics
SchrΓΆdinger
HQ: United States
Website
- Description: Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full SchrΓΆdinger company profile β
Custodix
HQ: Belgium
Website
- Description: Provider of clinical trial patient recruitment solutions, with offerings to ensure compliance with European and US data protection legislation and security best practices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Custodix company profile β
Seismic Therapeutic
HQ: United States
Website
- Description: Provider of machine-learning technology for immunology drug development, offering the IMPACT platform to accelerate novel biologics by integrating machine learning with structural biology, protein engineering, and translational immunology; Ig Sculpting Enzymes to modify pathogenic antibodies in autoimmune diseases, optimized for reduced immunogenicity while retaining enzyme activity; and Dual-cell Bidirectional antibodies engaging multiple inhibitory pathways in immune cells to restore immune homeostasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Seismic Therapeutic company profile β
BioAge Labs
HQ: United States
Website
- Description: Provider of clinical-stage therapeutics for obesity, metabolic, and neurodegenerative diseases. Offers Azelaprag, an oral APJ agonist to enhance weight loss and improve body composition alongside incretin drugs; BGE-100, a CNS-penetrant NLRP3 inhibitor targeting neuroinflammation; and a discovery platform analyzing multi-omics to identify aging and disease mediators and new drug targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full BioAge Labs company profile β
Nomic Bio
HQ: Canada
Website
- Description: Provider of a proteomic technology platform leveraging DNA nanotechnology to understand, detect, and treat diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Nomic Bio company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Epinomics
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Epinomics
2.2 - Growth funds investing in similar companies to Epinomics
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Epinomics
4.2 - Public trading comparable groups for Epinomics
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β